Vancouver, BC – LED Medical Diagnostics Inc. is pleased to announce that it has retained Bristol Capital Ltd. as its investor relations advisor. Bristol has been retained to assist LED Medical in achieving greater visibility amongst current and prospective investors through the dissemination and communication of corporate materials, conference calls and road show activity.
Bristol is headquartered in Vaughan, Ontario and does not presently own any securities of LED. Under the terms of the agreement, Bristol will receive $7,000 per month and 300,000 stock options exercisable at CDN$0.18 per share with an option term of three years. Vesting provisions provide that 25 per cent of the options will vest quarterly over the first year of the agreement. The agreement is for an initial 12-month term with a provision for automatic 12-month renewals. The agreement to retain Bristol Capital Ltd. is subject to TSX Venture Exchange approval.
“Bristol has an outstanding reputation of helping small emerging companies better communicate and build awareness with the professional investor community and we look forward to working with them in that regard,” stated Mr. David Gane, CEO.
